Impact of housing on the survival of persons with AIDS

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Schwarcz, Sandra K ^a,b   Hsu, Ling C ^a   Vittinghoff, Eric ^b   Vu, Annie ^a   Bamberger, Joshua D ^a   Katz, Mitchell H ^a,b  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HOMELESSNESS; HOUSING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; MIDDLE AGED; PATHOPHYSIOLOGY; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; FEMALE; HOMELESS PERSONS; HOUSING; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SAN FRANCISCO; SURVIVAL;

EID: 69149105110     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-220     Document Type: Article

References (56)

1. Deaths among the homeless in Fulton County, GA, 1988-90. R Hanzlick RG Parrish, Public Health Rep 1993 108 488 91 8341785
2. Mortality in a cohort of homeless adults in Philadelphia. JR Hibbs L Benner L Klugman R Spencer I Macchia A Mellinger DK Fife, N Engl J Med 1994 331 304 9 10.1056/NEJM199408043310506 8022442
3. Is homelessness hazardous to your health? Obstacles to the demonstration of a causal relationship. SW Hwang, Can J Public Health 2002 93 407 10 12448860
4. Mortality among homeless shelter residents in New York City. SM Barrow DB Herman P Cordova EL Struening, Am J Public Health 1999 89 529 34 10191796 10.2105/AJPH.89.4.529
5. The epidemiology of alcohol, drug, and mental disorders among homeless persons. PJ Fischer WR Breakey, Am Psychol 1991 46 1115 28 10.1037/0003-066X.46. 11.1115 1772149
6. Antiretroviral therapy, hepatitis C virus, and AIDS mortality among San Francisco's homeless and marginally housed. ED Riley DR Bangsberg D Guzman S Perry AR Moss, J Acquir Immune Defic Syndr 2005 38 191 5 10.1097/00126334- 200502010-00010 15671804
7. Psychiatric problems in homeless men. Lifetime psychosis, substance use, and current distress in new arrivals at New York City shelters. E Susser EL Struening S Conover, Arch Gen Psychiatry 1989 46 845 50 2774850
8. Depression among the homeless. M La Gory FJ Ritchey J Mullis, J Health Soc Behav 1990 31 87 102 10.2307/2137047 2313079
9. Brief report: Factors associated with depression among homeless and marginally housed HIV-infected men in San Francisco. SD Weiser ED Riley K Ragland G Hammer R Clark DR Bangsberg, J Gen Intern Med 2006 21 61 4 16423125 10.1111/j.1525-1497.2005.0282.x
10. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. AR Zolopa JA Hahn R Gorter J Miranda D Wlodarczyk J Peterson L Pilote AR Moss, JAMA 1994 272 455 61 10.1001/jama.272.6.455 8040981
11. Human immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infection. RA Torres S Mani J Altholz PW Brickner, Arch Intern Med 1990 150 2030 6 10.1001/archinte.150.10.2030 2121112
12. Viral hepatitis and other infectious diseases in a homeless population. RC Cheung AK Hanson K Maganti EB Keeffe SM Matsui, J Clin Gastroenterol 2002 34 476 80 10.1097/00004836-200204000-00021 11907367
13. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. WD Klinkenberg RJ Caslyn GA Morse RD Yonker S McCudden F Ketema NT Constantine, Compr Psychiatry 2003 44 293 302 10.1016/S0010-440X(03)00094-4 12923707
14. Health care utilization among homeless adults prior to death. SW Hwang JJ O'Connell JM Lebow MF Bierer EJ Orav TA Brennan, J Health Care Poor Underserved 2001 12 50 8 11217228
15. Factors associated with the health care utilization of homeless persons. MB Kushel E Vittinghoff JS Haas, JAMA 2001 285 200 6 10.1001/jama.285.2.200 11176814
16. The impact of housing status on health care utilization among persons with HIV disease. PS Arno KA Bonuck J Green J Fleishman CL Bennett MC Fahs C Maffeo E Drucker, J Health Care Poor Underserved 1996 7 36 49 8645784
17. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. DP Kidder RJ Wolitski ML Campsmith GV Nakamura, Am J Public Health 2007 97 2238 45 10.2105/AJPH.2006. 090209 17971562
18. Episodic homelessness and health care utilization in a prospective cohort of HIV-infected persons with alcohol problems. TW Kim SG Kertesz NJ Horton N Tibbetts JH Samet, BMC Health Serv Res 2006 6 19 16504167 10.1186/1472-6963-6-19
19. Predictors of medical service utilization among individuals with co-occurring HIV infection and substance abuse disorders. CL Masson JL Sorensen CS Phibbs RL Okin, AIDS Care 2004 16 744 55 10.1080/09540120412331269585 15370062
20. Housing status and health care service utilization among low-income persons with HIV/AIDS. MY Smith BD Rapkin G Winkel C Springer R Chhabra IS Feldman, J Gen Intern Med 2000 15 731 8 11089717 10.1046/j.1525-1497.2000.91003. x
21. Self-reported antiretroviral therapy in injection drug users. DD Celentano D Vlahov S Cohn VM Shadle O Obasanjo RD Moore, JAMA 1998 280 544 6 10.1001/jama.280.6.544 9707145
22. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. AR Moss JA Hahn S Perry ED Charlebois D Guzman RA Clark DR Bangsberg, Clin Infect Dis 2004 39 1190 8 10.1086/424008 15486844
23. AIDS among the homeless of Boston: a cohort study. JM Lebow JJ O'Connell S Oddleifson KM Gallagher Seage GR 3rd KA Freedberg, J Acquir Immune Defic Syndr Hum Retrovirol 1995 8 292 6 10.1097/00042560-199503010-00011 7859142
24. Predicting death from HIV/AIDS: a case-control study from Florida public HIV/AIDS clinics. S Lieb RG Brooks RS Hopkins D Thompson LK Crockett T Liberti AA Jani JP Nadler VM Virkud KC West, et al. J Acquir Immune Defic Syndr 2002 30 351 8 12131573
25. Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems. AY Walley DM Cheng H Libman D Nunes Horsburgh CR Jr R Saitz JH Samet, AIDS 2008 22 415 20 18195568 10.1097/QAD.0b013e3282f423f8
26. The San Francisco Department of Public Health HIV/AIDS Epidemiology Report, 2006. The San Francisco Department of Public Health, 2007 51
27. Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). AJ Saah DR Hoover Y He LA Kingsley JP Phair, J Acquir Immune Defic Syndr 1994 7 287 95 8106968
28. Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. A Mocroft M Youle J Morcinek CA Sabin B Gazzard MA Johnson AN Phillips, BMJ 1997 314 409 13 9040386
29. Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. AN Phillips B Gazzard R Gilson P Easterbrook M Johnson J Walsh C Leen M Fisher C Orkin J Anderson, et al. AIDS 2007 21 1717 21 10.1097/QAD.0b013e3282170a9d 17690569
30. Statistical analysis of cost-effectiveness data. BA Willan AR, West Sussex, England: Wiley 2006
31. An Introduction to the Bootstrap. TR Efron B, Boca Raton: Chapman & Hall/CRC 1998
32. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. JE Sackoff DB Hanna MR Pfeiffer LV Torian, Ann Intern Med 2006 145 397 406 16983127
33. Trends in predictors of death due to HIV-related causes among persons living with AIDS in New York City: 1993-2001. D Nash M Katyal S Shah, J Urban Health 2005 82 584 600 16237203
34. Factors associated with premature mortality among young injection drug users in Vancouver. CL Miller T Kerr SA Strathdee K Li E Wood, Harm Reduct J 2007 4 1 17201933 10.1186/1477-7517-4-1
35. Mortality risk among new onset injection drug users. D Vlahov CL Wang N Galai J Bareta SH Mehta SA Strathdee KE Nelson, Addiction 2004 99 946 54 10.1111/j.1360-0443.2004.00780.x 15265091
36. Changing patterns in causes of death in a cohort of injecting drug users, 1980-2001. L Copeland J Budd JR Robertson RA Elton, Arch Intern Med 2004 164 1214 20 10.1001/archinte.164.11.1214 15197047
37. Impact of HIV infection on mortality in a cohort of injection drug users. MW Tyndall KJ Craib S Currie K Li MV O'Shaughnessy MT Schechter, J Acquir Immune Defic Syndr 2001 28 351 7 11707672
38. HIV/AIDS Surveillance Report, 2007. CDC, 2009 19 9
39. Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004. L Espinoza HI Hall F Hardnett RM Selik Q Ling LM Lee, Am J Public Health 2007 97 144 9 17138918 10.2105/AJPH.2005.077461
40. Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS. S Schwarcz L Hsu JW Dilley L Loeb K Nelson S Boyd, J Acquir Immune Defic Syndr 2006 43 491 4 10.1097/01.qai.0000243114.37035.de 17031318
41. The link between public and private insurance and HIV-related mortality. J Bhattacharya D Goldman N Sood, J Health Econ 2003 22 1105 22 10.1016/j.jhealeco.2003.07.001 14604563
42. Variation in inpatient resource use in the treatment of HIV: do the privately insured receive more care? GF Joyce DP Goldman A Leibowitz D Carlisle N Duan MF Shapiro SA Bozzette, Med Care 1999 37 220 7 10.1097/00005650- 199903000-00002 10098566
43. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization. WE Cunningham LE Markson RM Andersen SH Crystal JA Fleishman C Golin A Gifford HH Liu TT Nakazono S Morton, et al. J Acquir Immune Defic Syndr 2000 25 115 23 10.1097/00042560-200010010-00005 11103041
44. Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999. LC Hsu E Vittinghoff MH Katz SK Schwarcz, J Acquir Immune Defic Syndr 2001 28 345 50 11707671
45. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. MF Shapiro SC Morton DF McCaffrey JW Senterfitt JA Fleishman JF Perlman LA Athey JW Keesey DP Goldman SH Berry, et al. JAMA 1999 281 2305 15 10.1001/jama.281.24.2305 10386555
46. Impact of permanent supportive housing on the use of acute care health services by homeless adults. TE Martinez MR Burt, Psychiatr Serv 2006 57 992 9 10.1176/appi.ps.57.7.992 16816284
47. Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. S Tsemberis L Gulcur M Nakae, Am J Public Health 2004 94 651 6 15054020 10.2105/AJPH.94.4.651
48. Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. LS Sadowski RA Kee TJ Vander Weele D Buchanan, Jama 2009 301 1771 8 10.1001/jama.2009.561 19417194
49. Cost-effectiveness of supported housing for homeless persons with mental illness. R Rosenheck W Kasprow L Frisman W Liu-Mares, Arch Gen Psychiatry 2003 60 940 51 10.1001/archpsyc.60.9.940 12963676
50. Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. MB Kushel G Colfax K Ragland A Heineman H Palacio DR Bangsberg, Clin Infect Dis 2006 43 234 42 10.1086/505212 16779752
51. Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. MH Katz WE Cunningham JA Fleishman RM Andersen T Kellogg SA Bozzette MF Shapiro, Ann Intern Med 2001 135 557 65 11601927
52. Housing status and HIV risk behaviors: implications for prevention and policy. A Aidala JE Cross R Stall D Harre E Sumartojo, AIDS Behav 2005 251 65 10.1007/s10461-005-9000-7 16088369
53. Cost and threshold analysis of housing as an HIV prevention intervention. DR Holtgrave K Briddell E Little AV Bendixen M Hooper DP Kidder RJ Wolitski D Harre S Royal A Aidala, AIDS Behav 2007 11 162 6 10.1007/s10461-007-9274-z 17616800
54. Evaluating the cost-effectiveness of clinical and public health measures. JD Graham PS Corso JM Morris M Segui-Gomez MC Weinstein, Annu Rev Public Health 1998 19 125 52 10.1146/annurev.publhealth.19.1.125 9611615
55. Medicare and cost-effectiveness analysis. PJ Neumann AB Rosen MC Weinstein, N Engl J Med 2005 353 1516 22 10.1056/NEJMsb050564 16207857
56. The New York/New York agreement cost study: the impact of supportive housing on service use for homeless mentally ill individuals. T Houghton, Corporation for Supportive Housing, New York, New York 2001